| Lewy pathology in Parkinson’s disease consists of crowded organelles and lipid membranes SH Shahmoradian, AJ Lewis, C Genoud, J Hench, TE Moors, PP Navarro, ... Nature neuroscience 22 (7), 1099-1109, 2019 | 825 | 2019 |
| Therapeutic potential of autophagy-enhancing agents in Parkinson’s disease TE Moors, JJM Hoozemans, A Ingrassia, T Beccari, L Parnetti, ... Molecular neurodegeneration 12, 1-18, 2017 | 318 | 2017 |
| Microglial phenotypes and toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson’s disease patients KJ Doorn, T Moors, B Drukarch, WDJ van de Berg, PJ Lucassen, ... Acta neuropathologica communications 2, 1-17, 2014 | 305 | 2014 |
| Lysosomal dysfunction and α‐Synuclein aggregation in Parkinson's disease: diagnostic links T Moors, S Paciotti, D Chiasserini, P Calabresi, L Parnetti, T Beccari, ... Movement Disorders 31 (6), 791-801, 2016 | 158 | 2016 |
| Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson’s Disease and Dementia with Lewy Bodies TE Moors, S Paciotti, A Ingrassia, M Quadri, G Breedveld, A Tasegian, ... Molecular neurobiology 56, 1344-1355, 2019 | 129 | 2019 |
| The subcellular arrangement of alpha-synuclein proteoforms in the Parkinson’s disease brain as revealed by multicolor STED microscopy TE Moors, CA Maat, D Niedieker, D Mona, D Petersen, ... Acta neuropathologica 142, 423-448, 2021 | 89 | 2021 |
| Path mediation analysis reveals GBA impacts Lewy body disease status by increasing α-synuclein levels AL Gündner, G Duran-Pacheco, S Zimmermann, I Ruf, T Moors, ... Neurobiology of disease 121, 205-213, 2019 | 58 | 2019 |
| Dynamic physiological α-synuclein S129 phosphorylation is driven by neuronal activity N Ramalingam, SX Jin, TE Moors, L Fonseca-Ornelas, K Shimanaka, ... npj Parkinson's Disease 9 (1), 4, 2023 | 46 | 2023 |
| Lewy pathology in Parkinson’s disease consists of a crowded organellar, membranous medley SH Shahmoradian, AJ Lewis, C Genoud, J Hench, T Moors, PP Navarro, ... biorxiv, 137976, 2017 | 33 | 2017 |
| Wild-type GBA1 increases the α-synuclein tetramer–monomer ratio, reduces lipid-rich aggregates, and attenuates motor and cognitive deficits in mice KE Glajch, TE Moors, Y Chen, PA Bechade, AY Nam, MM Rajsombath, ... Proceedings of the National Academy of Sciences 118 (31), e2103425118, 2021 | 27 | 2021 |
| Subcellular orchestration of alpha-synuclein variants in Parkinson’s disease brains revealed by 3D multicolor STED microscopy TE Moors, CA Maat, D Niedieker, D Mona, D Petersen, ... bioRxiv, 470476, 2018 | 12 | 2018 |
| Detailed structural orchestration of Lewy pathology in Parkinson’s disease as revealed by 3D multicolor STED microscopy TE Moors, CA Maat, D Niedieker, D Mona, D Petersen, ... Biorxiv, 470476, 2018 | 12 | 2018 |
| Multi-platform quantitation of alpha-synuclein human brain proteoforms suggests disease-specific biochemical profiles of synucleinopathies TE Moors, D Mona, S Luehe, G Duran-Pacheco, L Spycher, O Mundigl, ... Acta neuropathologica communications 10 (1), 82, 2022 | 10 | 2022 |
| The orchestration of subcellular alpha-synuclein pathology in the Parkinson’s disease brain revealed by STED microscopy TE Moors, CA Maat, D Niedieker, D Mona, D Petersen, ... bioRxiv, 2018 | 9 | 2018 |
| Alterations in sub-axonal architecture between normal aging and Parkinson’s diseased human brains using label-free cryogenic X-ray nanotomography HT Tran, EHR Tsai, AJ Lewis, T Moors, J Bol, I Rostami, A Diaz, AJ Jonker, ... Frontiers in neuroscience 14, 570019, 2020 | 8 | 2020 |
| Origin of α-mannosidase activity in CSF A Tasegian, S Paciotti, MR Ceccarini, M Codini, T Moors, D Chiasserini, ... The international journal of biochemistry & cell biology 87, 34-37, 2017 | 7 | 2017 |
| Lewy pathology in Parkinson’s disease consists of a crowded organellar membranous medley. bioRxiv 137976 SH Shahmoradian, C Genoud, A Graff-Meyer, J Hench, T Moors, ... | 7 | 2017 |
| Increased palmitoylation improves estrogen receptor alpha–dependent hippocampal synaptic deficits in a mouse model of synucleinopathy TE Moors, S Li, TD McCaffery, GPH Ho, PA Bechade, LN Pham, ... Science Advances 9 (46), eadj1454, 2023 | 4 | 2023 |
| Generation of G51D and 3D mice reveals decreased α-synuclein tetramer-monomer ratios promote Parkinson’s disease phenotypes S Nuber, X Zhang, TD McCaffery, TE Moors, MA Adom, WN Hahn, ... npj Parkinson's Disease 10 (1), 47, 2024 | 3 | 2024 |
| Defining a Lewy Body: Running Up the Hill of Shifting Definitions and Evolving Concepts TE Moors, D Milovanovic Journal of Parkinson's Disease, 1-17, 2024 | 2 | 2024 |
